The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Statement regarding the call option purchased by Orchestra Group
With reference to the announcement of 24th September, "Director PDMR / Shareholding", relating to the purchase of a call option for consideration by Orchestra Group, the Company has been informed by Mr Zamboni, for clarification purposes, that the instrument is an arms-length arrangement with a regulated institutional entity which is not a related party of Orchestra Group.
Following the announcement of 10th September pursuant to the confidentiality agreements signed with its Partners and Client companies, the Company looks forwards to updating shareholders further on its business operations and their related financial impacts in the coming days.
Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com
Paul Vann, Walbrook PR Limited: +44 (0)20 7933 8780; paul.vann@walbrookpr.com
Brian Norris, Cicero/AMO, +44 (0)20 7947 5317, Brian.norris@cicero-group.com
24 September 2020
Braveheart Investment Group plc
("Braveheart" or "the Group")
Update on Phasefocus Holdings Limited
Braveheart Investment Group (AIM: BRH), is pleased to provide an operations update on Phasefocus Holdings Limited ("Phasefocus"), the computational imaging technology company in which Braveheart owns 42.67 per cent. of the issued share capital.
The Phasefocus Virtual Lens™ is a novel method for high fidelity quantitative phase imaging and microscopy that has a wide range of applications including live cell imaging, engineering metrology and electron microscopy.
The switch to online sales meetings and virtual demonstrations for its high value instrument is proving successful. With life science research laboratories working hard throughout the pandemic Phasefocus continues to have a strong sales pipeline for Livecyte2™ instruments and received orders from customers in Italy, Israel and China, as well as software and hardware upgrades to existing Livecyte™ users at York, Manchester and Hull Universities, the Francis Crick Institute and others.
As well as original equipment sales to customers, Phasefocus is seeing a growing demand for long term service contracts. Phasefocus sees this as an excellent opportunity to increase guaranteed revenues, whilst providing users with certainty that they continue to operate at the forefront of the scientific capability, through regular system updates and servicing.
The Livecyte2™ software is already a market leader enabling users to record, track and classify the responses of individual live cells, grown in the laboratory, as they are subjected to drugs. Phasefocus is now working, in collaboration with the Manchester University, to further enhance LiveCyte™ using Artificial Intelligence ("AI") based image classification.
18 September 2020
Braveheart Investment Group plc
("Braveheart" or the "Group")
Update on the Pharm2Farm anti-viral mask project
Braveheart Investment Group (AIM: BRH), is pleased to announce that Pharm 2 Farm Limited ("P2F") has placed an order for an automated face mask production line which is expected to be delivered in November 2020 and commissioned by the end of December 2020.
The face mask production line, which is manufactured in Europe, has the capacity to produce up to five million standard or anti-viral face masks per month.
Conventional surgical type masks typically comprise of three layers, with the inner layer acting as a physical barrier to viruses and bacteria. However, they are only recommended for up to two hours of continual use as this layer can become moist and fail, thereby allowing the virus to penetrate though. P2F has developed a second defensive layer that incorporates its own nanotechnology, which is engineered to kill viruses and bacteria. Combining this new active layer with the physical barrier layer, to produce four layer (ply) masks, is expected to improve user safety over a prolonged use. This new material is currently undergoing testing, specifically, with respect to the time taken to kill viruses, including COVID-19. These tests are, being undertaken at the University of Nottingham and results are expected by the beginning of October. Following a satisfactory outcome of the tests undertaken at the University of Nottingham, it is envisaged that manufacture of the anti-viral face masks will commence in the first quarter of 2021. In the event that these tests do not provide a satisfactory outcome, the production line will be used to produce conventional surgical type masks, which P2F believe could still be produced on a profitable basis.
("Eurasia" or "the Company")
Appointments of Chief Executive Officer, Chief M&A Officer and Board Changes
Eurasia Mining plc, the palladium, platinum, rhodium, iridium and gold producing company, operating the established West Kytlim Mine in the Urals, and also the operator of the Monchetundra Project comprising two predominantly palladium open pit deposits near base metal and PGM processing facilities close to the town of Monchegorsk on the Kola Peninsula, is pleased to announce the appointment of James Nieuwenhuys, formerly a Non-Executive Director, as Chief Executive Officer and Executive Director of the Company with immediate effect. Christian Schaffalitzky remains as Executive Chairman. The Directors have agreed to release Dmitry Suschov from the Board in order to allow him to focus as the Company's Chief M&A Officer on the M&A work streams with Eurasia's professional advisers.
Mr Nieuwenhuys has held senior positions including Chief Executive Officer at South African Lesego Platinum Mining Limited, Chief Operating Officer at Polyus Gold, Russian largest gold producer. James also held senior positions at a number of EPC organisations. The Directors believe that the experience of James and his relationships especially among PGM producers in Russia, China and South Africa, are beneficial for the Company in its ongoing work streams.
Mr Suschov has a successful track record of leading the strategic sales of companies in the natural resource sector including the sale of a silica sand mine and the second largest global carborundum production company to Indian Murugappa Group, the sale of a natural resource company to Danish natural resource fund, the sale of a gas company to a major Russian investment group and other deals.
Comments
Christian Schaffalitzky, Eurasia's Executive Chairman commented: "This reorganization is designed to optimise our execution team. We are delighted that James has agreed to take on the CEO role. James's focus will be to work with our advisers on the sale process. Since joining Eurasia in November 2019 after completing due diligence on behalf of a potential buyer, James has got detailed knowledge of Eurasia's assets and he is of immense help both in terms of the sale process and in terms of demonstrating to the interested parties the strength of our own management team and its capacity to execute. Dmitry changes his routine Board roles for the role of Chief M&A Officer and together with James will strengthen the management team involved in the work streams with several interested parties. We are grateful to Dmitry for his long-term hard work on the Board level over 10 years and the Directors look forward to working with him in his new capacity".
James Nieuwenhuys, Eurasia's CEO and Executive Director: "In my new capacity as CEO and Executive Director I will continue to work with our advisers on the sale process of the Company and its world class assets, Monchetundra and West Kytlim, leveraging my r
Supply@Me Capital plc
(The "Company", "SYME" or "Supply@Me")
Response to erroneous media article
Supply@ME Capital plc, the innovative fintech platform which provides a unique, market leading Inventory Monetisation© service to European manufacturing and trading companies, is aware that a totally erroneous article reviewing a series of fabricated SYME forecasts was issued yesterday afternoon. This appeared on more than one "fake news" website.
SYME wishes to make clear that the article was both inaccurate and misleading and that it totally dissociates itself with the content.
The Company notes that, pursuant to its Social Media Policy, it monitors and reviews online media activity so that where required it can highlight erroneous information that could cause confusion and erratic price movements.
The Directors of SYME expect to announce more detailed updates on its inventory funding and client company origination partnerships across all regions via the Regulatory News Service of The London Stock Exchange in the coming days.
Notes
Supply@ME enables businesses to generate cashflow, without incurring debt, by monetising their existing stock. Before a business has found an end-customer for its inventory, the Supply@ME platform enables them to sell ("monetise") their stock and receive cash immediately to boost their working capital. The Supply@ME service enables strong companies to improve their working capital cycle. SYME does not monetise inventory for companies in financial difficulty or with inventory that they are struggling to sell.
FOR IMMEDIATE RELEASE
11 September 2020
Amigo Holdings PLC
("Amigo" or the "Company")
Notice of General Meeting and Posting of Circular
On 27 August 2020, Amigo announced that it had received a formal notice from Richmond Group Limited ("RGL") requisitioning a general meeting of the Company's shareholders (the "Requisition Notice").
The Requisition Notice (as subsequently amended by RGL) proposes the following resolutions (the "Resolutions") relating to the appointment and removal of directors of Amigo Holdings PLC and the appointment of directors to the Company's regulated subsidiary, Amigo Loans Ltd:
1. THAT James Benamor is appointed as a director of Amigo Holdings PLC with immediate effect.
2. THAT Nayan Kisnadwala is removed as a director of Amigo Holdings PLC with immediate effect.
3. THAT Roger Lovering is removed as a director of Amigo Holdings PLC with immediate effect.
4. THAT Glen Crawford is appointed as a director of Amigo Loans Ltd with immediate effect.
5. THAT Gary Jennison is appointed as a director of Amigo Loans Ltd with immediate effect.
6. THAT Richard Price is appointed as a director of Amigo Loans Ltd with immediate effect.
7. THAT Jonathan Roe is appointed as a director of Amigo Loans Ltd with immediate effect.
The Company confirms that a circular incorporating notice of a general meeting, to be held at 10.45 a.m. on 29 September 2020 at Nova, 118-128 Commercial Road, Bournemouth, England, BH2 5LT or as soon thereafter as the Company's Annual General Meeting (which has been convened at 10.30 a.m. on the same day at the same location) (the "General Meeting"), has been posted to the Company's shareholders today (the "Circular").
The purpose of the General Meeting is to give shareholders the opportunity to vote on the Resolutions which force the Board to take steps which, for the reasons summarised below and as detailed further in the Circular, it believes are not in the best interest of the Company or its shareholders as a whole.
The Board unanimously recommends that shareholders VOTE AGAINST the Resolutions for the following reasons:
· If the Resolutions are passed, the Company will have no Executive Directors and, in summary, the following positions will be vacant:
Position
Status
Chair
Vacant (pending FCA approval of Jonathan Roe*)
Senior Independent Director
Vacant
Chair of the Risk Committee
Vacant (pending FCA approval of Gary Jennison*)
Chair of the Nomination Committee
Vacant (pending FCA approval of Jonathan Roe*)
CEO
Vacant (the CEO designate, Glen Crawford* will resign immediately and Mr. Benamor will not be automatically appointed)
CFO
Vacant
* Formal applications have been made to the Financial Conduct Authority ("FCA") for Glen Crawford, Jonathan Roe and Gary Jennison to take up the indicate
newbies . this how it works .. mms will buy off u at 10p and they state sell to u at 11p . wot they do tho is actually buy off u at 10 p and sell to at 10 .1 p and alogorithm registers everything as a sell and so even if every1 is buying it goes to a 10 % loss which will trigger stop losses so mms get more cheap shares to fill buy orders . hold ure shares and dont panick . this share will fly soon
tyla .. at 12p im a millionaire . i believe in this concept and want to put more cash in but other shares need to come good soon .. eua .. brh and amgo .. i sold a lot of other shares to put cash into this project , hold and i think we will be rewarded bigly . gla
nearly all sells when i checked earlier were buys . the share price is being manipulated to fill big buy orders . i am down £20 grand these last 2 days but at this time a happy chappy . just wish wish eua would sell so i could invest more here . think this share is going to b a monster . gla .. dyor
alue
10-Sep-20 16:18:59 0.50 1,661,398 Buy* 0.49 0.50 8,307 O
10-Sep-20 16:15:06 0.50 1,500,000 Buy* 0.49 0.50 7,500 O
09-Sep-20 08:21:17 0.57 9,471,916 Buy* 0.49 0.50 53.99k O
09-Sep-20 15:14:42 0.5489 5,437,015 Buy* 0.49 0.50 29.84k O
09-Sep-20 16:30:08 0.554 5,437,015 Buy* 0.49 0.50 30.12k O
09-Sep-20 12:00:08 0.5585 5,000,000 Buy* 0.49 0.50 27.93k O
09-Sep-20 08:23:46 0.57 5,235,759 Buy* 0.49 0.50 29.84k O
09-Sep-20 08:21:16 0.57 4,000,000 Buy* 0.49 0.50 22.80k O
09-Sep-20 15:55:16 0.559 10,000,000 Buy* 0.49 0.50 55.90k O
09-Sep-20 09:59:32 0.5641 4,000,000 Buy* 0.49 0.50 22.56k O
09-Sep-20 15:37:16 0.54 5,000,000 Buy* 0.49 0.50 27.00k O
09-Sep-20 15:35:28 0.54 5,000,000 Buy* 0.49 0.50 27.00k O
09-Sep-20 08:54:07 0.56 5,000,000 Buy* 0.49 0.50 28.00k O
09-Sep-20 09:24:39 0.55 5,000,000 Buy* 0.49 0.50 27.50k O
09-Sep-20 09:13:19 0.55 10,000,000 Buy* 0.49 0.50 55.00k O
09-Sep-20 14:26:31 0.5526 5,000,000 Buy* 0.49 0.50 27.63k O
09-Sep-20 09:07:54 0.5671 4,189,200 Buy* 0.49 0.50 23.76k O
09-Sep-20 08:58:10 0.56 5,000,000 Buy* 0.49 0.50 28.00k O
10-Sep-20 16:14:45 0.50 1,989,256 Buy* 0.49 0.50 9,946 O
10-Sep-20 15:13:40 0.51333 2,500,000 Buy* 0.49 0.50 12.83k O
10-Sep-20 16:13:29 0.498 2,500,000 Buy* 0.49 0.50 12.45k O
10-Sep-20 17:10:57 0.50 1,570,000 Buy* 0.49 0.50 7,850 O
10-Sep-20 16:07:28 0.494 2,500,000 Sell* 0.49 0.50 12.35k O
10-Sep-20 16:06:23 0.499 1,992,851 Buy* 0.49 0.50 9,944 O
10-Sep-20 16:02:52 0.4966 2,500,000 Buy* 0.49 0.50 12.42k O
10-Sep-20 15:52:37 0.50 2,000,000 Buy* 0.49 0.50 10,000 O
10-Sep-20 15:50:37 0.50 2,000,000 Buy* 0.49 0.50 10,000 O
10-Sep-20 15:47:28 0.5005 1,999,191 Buy* 0.49 0.50 10.01k O
10-Sep-20 15:46:33 0.503 1,989,255 Buy* 0.49 0.50 10.01k O
10-Sep-20 16:37:35 0.51236 35,000,000 Buy* 0.49 0.50 179.33k O
10-Sep-20 16:35:16 0.50 5,923,182 Buy* 0.49 0.50 29.62k UT
10-Sep-20 15:34:34 0.5125 1,800,000 Buy* 0.49 0.50 9,225
(The "Company", "SYME" or "Supply@Me")
Inventory funding and institutional investors relationship update
Supply@ME Capital plc, the innovative fintech platform which provides a unique, market leading Inventory Monetisation© service to European manufacturing and trading companies, is pleased to announce the following updates.
1. Securitised Note Issuance (through StormHarbour Securities)
As planned, the Company has received offers, subject to contract, from a number of large, global institutional investors, to provide funding, in the form of securitisation notes, in order to monetise more than €300m of inventory. There has been strong demand from a number of investment funds (including private equity and multilateral financial institutions supporting businesses that are promoting post COVID growth) which are individually requesting exclusivity for the securitisation notes issuance, and which are also remaining available for strategic support to the Company for the next funding rounds. The Company is currently analysing whether to syndicate this first securitisation issuance or work on an exclusive basis with one of the Funds mentioned above. Meanwhile SYME is keen to complete the signing of binding contracts with regard to the Client companies forming part of the securitisation portfolio by the end of September.
2. UK Programme
The funding due diligence provided by a leading UK capital markets organisation has been positively completed. The Company is negotiating a funding term sheet in order to commence delivery of the inventory monetisation service in respect of the first portfolio of UK Client companies.
3. Italian Sell-funding agreements
The Company has agreed the key terms of the partnership with 2 local Banks. With one of these, the Parties are studying a more extended relationship. Pursuant to banking regulation, the agreements with SYME will be approved by the relevant internal committees by the end of September.
Furthermore, the Company has been invited to a tender promoted by Finlombarda (the main Lombardy public bank) in relation to fintech services to be provided to local SMEs.
4. Middle-East Programme
A Shari'a assessment on the Supply@ME Platform provided by an internal specialised department of a global bank has been positively completed. This Bank has also identified a local Funding Partner available to support the UAE Programme of SYME and iMass (MENA strategic Partner - as announced by SYME in the RNS of 10 August).
The Parties above are currently agreeing a Memorandum of Understanding, details of which will be published in a separate announcement.
5. Institutional equity agreements
By virtue of the huge underserved market and the unique - proven - inventory monetisation service, the strategic Partners above have been asking to SYME to invest - directly or indirectly - into the capital of the Company, pursuant to confidentiality agreements in place re
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
The AvantGarde Group SpA
2.
Reason for the Notification
a)
Position/status
Alessandro Zamboni CEO Supply@ME Capital plc
Alessandro Zamboni, Sole Director of The AvantGarde Group S.p.A.
b)
Initial notification/amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Supply@Me Capital Plc
b)
LEI
213800ZY2C2TI2C5WQ61
4.
Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary shares of 0.002p each in the share capital of Supply@Me Capital plc
Identification code
ISIN: GB00BFMDJC60
b)
Nature of the Transaction
Direct transfer to custody account
c)
Price(s) and volume(s)
Price(s)
Volume(s)
0.6872 pence
940,000,000
d)
Aggregated information
Aggregated volume Price
None
e)
Date of the transaction
7 September 2020
f)
Place of the transaction
London Stock Exchange
% of voting rights attached to shares (total of 8. A)
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached
54.06%
54.06%
32,754,944,590
Position of previous notification (if
applicable)
56.93%
56.93%
Amigo Holdings PLC
("Amigo" or the "Company")
Response to social media speculation
The Board of Amigo notes the social media comments from James Benamor over the weekend in which he provides an extract of the terms of an irrevocable instruction which Richmond Group Limited ("RGL") has purportedly entered into with its broker to acquire up to 29% of the share capital of the Company at up to 20 pence per share (a link to the post is here).
Amigo will be posting its Notice of General Meeting as requisitioned by RGL on or before Friday 11th September, which will include a recommendation to shareholders to VOTE AGAINST all resolutions proposed by RGL.
In the meantime, Amigo cautions its shareholders to be aware of the following aspects of the irrevocable instruction:
· RGL's offer to start acquiring shares is conditional on Mr Benamor being appointed CEO of Amigo and not upon him being elected to be a director of Amigo.
· Even if the resolution to elect Mr. Benamor to the Board is passed at the forthcoming General Meeting, Mr. Benamor will not automatically become CEO. His appointment to the position of CEO requires the approval of the Board of Amigo and the subsequent approval of the FCA. There is no guarantee approval will be granted.
· Further, RGL will in any event require the prior approval of the FCA to acquire 20% or more of Amigo shares and thereby become a "controller" of a regulated entity. There is no guarantee either that this further approval will be granted. This will limit any share purchase by RGL up to 20%. In the absence of the required prior approval from the FCA, execution of the irrevocable instruction would result in RGL committing a criminal offence when its shareholding exceeds 20%.
· Amigo notes the speculation by Mr. Benamor that the Board may be considering a share buyback. This is not the case. There are no current plans to buyback any shares of Amigo. The resolution proposed at the forthcoming Annual General Meeting is a standard authorisation resolution which is sought on a recurring basis by most listed public companies at their Annual General Meetings and is in line with The Investment Association's Share Capital Management Guidelines.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014. The person responsible for this announcement is Roger Bennett, Company Secretary.